Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors at their meeting held on August 28, 2023 noted and approved the following: a. The Letter of resignation of Mr. Duraiswami Narain ( DIN: 03310642) as the Vice Chairman & Managing Director and Chief Executive Officer of the Company w.e.f. October 31, 2023 due to his planned repatriation to Bayer US. b. The letter of resignation of Mr. Simon Weibusch , Executive Director (DIN: 08335591) as the Whole-time Director of the Company w.e.f. October 31, 2023. c. Appointment of Mr. Simon Wiebusch (DIN: 08335591) as the Vice Chairman, Managing Director and CEO of the Company w.e.f. November 1, 2023.